Ace (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Ace (angiotensin I converting enzyme (peptidyl-dipeptidase A) 1) Mus musculus
Analyze
Symbol: Ace
Name: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
RGD ID: 10468
MGI Page MGI
Description: Enables metallopeptidase activity and peptidyl-dipeptidase activity. Involved in several processes, including angiotensin maturation; positive regulation of protein modification process; and regulation of gene expression. Acts upstream of or within several processes, including heart contraction; neutrophil mediated immunity; and positive regulation of systemic arterial blood pressure. Located in cytoplasm and plasma membrane. Is expressed in several structures, including alimentary system; brain; extraembryonic component; genitourinary system; and integumental system. Human ortholog(s) of this gene implicated in several diseases, including artery disease (multiple); autoimmune disease (multiple); gastrointestinal system cancer (multiple); heart valve disease (multiple); and lung disease (multiple). Orthologous to human ACE (angiotensin I converting enzyme).
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: angiotensin converting enzyme; angiotensin-converting enzyme; AW208573; CD143; dipeptidyl carboxypeptidase I; dipeptidyl peptidase; kininase II; MGC117827
RGD Orthologs
Human
Rat
Bonobo
Dog
Squirrel
Pig
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm3911105,858,774 - 105,880,790 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl11105,858,771 - 105,880,790 (+)EnsemblGRCm39 Ensembl
GRCm3811105,967,948 - 105,989,964 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl11105,967,945 - 105,989,964 (+)EnsemblGRCm38mm10GRCm38
MGSCv3711105,829,261 - 105,851,259 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv3611105,784,049 - 105,805,350 (+)NCBIMGSCv36mm8
Celera11117,699,475 - 117,721,491 (+)NCBICelera
Cytogenetic Map11E1NCBI
cM Map1168.84NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
abdominal aortic aneurysm  (ISO)
Acute Hepatitis  (ISO)
acute kidney failure  (ISO)
Acute Lung Injury  (IEP)
adenocarcinoma  (ISO)
adult respiratory distress syndrome  (ISO)
Albuminuria  (ISO)
alcoholic cardiomyopathy  (ISO)
Alcoholic Liver Diseases  (ISO)
allergic disease  (ISO)
allergic rhinitis  (ISO)
Alzheimer's disease  (ISO)
anemia  (ISO)
Angiotensin I-Converting Enzyme, Benign Serum Increase  (ISO)
ankylosing spondylitis  (ISO)
Aortic Coarctation  (ISO)
Arteriovenous Fistula  (ISO)
aspiration pneumonia  (ISO)
asthma  (ISO)
atrial fibrillation  (ISO)
autistic disorder  (ISO)
autosomal recessive polycystic kidney disease  (ISO)
Banti's Syndrome  (ISO)
Behcet's disease  (ISO)
berylliosis  (ISO)
bipolar disorder  (IEA)
brain ischemia  (ISO)
breast cancer  (ISO)
bronchiolitis obliterans  (ISO)
CAKUT  (ISO)
Cardiac Arrhythmias  (ISO)
Cardiomegaly  (ISO)
cardiovascular system disease  (ISO)
carotid artery disease  (ISO)
celiac disease  (ISO)
Cerebral Hemorrhage  (ISO)
cerebral infarction  (ISO)
Chemical and Drug Induced Liver Injury  (ISO)
chemical colitis  (IEP)
Chemotherapy-Induced Febrile Neutropenia  (ISO)
cholestasis  (ISO)
Chronic Hepatitis C  (ISO)
Chronic Intermittent Hypoxia  (ISO)
chronic myeloid leukemia  (ISO)
chronic obstructive pulmonary disease  (ISO)
congenital diaphragmatic hernia  (ISO)
Congenital Hepatic Fibrosis  (ISO)
congestive heart failure  (ISO)
coronary artery disease  (ISO)
Coronary Disease  (ISO)
coronary restenosis  (ISO)
Coronavirus infectious disease  (ISO)
Cough  (ISO)
COVID-19  (ISO)
Cytomegalovirus Infections  (ISO)
diabetic angiopathy  (ISO)
Diabetic Cardiomyopathies  (ISO)
Diabetic Nephropathies  (ISO)
diabetic retinopathy  (ISO)
diastolic heart failure  (ISO)
diffuse cystic renal dysplasia  (ISO)
dilated cardiomyopathy  (ISO)
drug allergy  (ISO)
end stage renal disease  (ISO)
endomyocardial fibrosis  (ISO)
Endotoxemia  (ISO)
Experimental Arthritis  (ISO)
Experimental Colitis  (IMP)
Experimental Diabetes Mellitus  (ISO)
Experimental Liver Cirrhosis  (ISO)
extrinsic allergic alveolitis  (ISO)
Fabry disease  (ISO)
Familial Cerebral Cavernous Malformation  (ISO)
familial Mediterranean fever  (ISO)
Fetal Death  (ISO)
Fetal Growth Retardation  (ISO)
focal segmental glomerulosclerosis 1  (ISO)
gallbladder adenocarcinoma  (ISO)
Gaucher's disease  (ISO)
Genetic Predisposition to Disease  (ISO)
glomerulonephritis  (ISO)
glomerulosclerosis  (ISO)
glycogen storage disease V  (ISO)
heart valve disease  (ISO)
Helicobacter Infections  (ISO)
Henoch-Schoenlein purpura  (ISO)
hepatitis A  (ISO)
hepatocellular carcinoma  (ISO)
Hyperoxia  (ISO)
hypertension  (IMP,ISO)
Hypertensive Nephrosclerosis  (ISO)
hypertrophic cardiomyopathy  (ISO)
Hypotension  (ISO)
IgA glomerulonephritis  (ISO)
in situ carcinoma  (IMP)
Insulin Resistance  (ISO)
intermediate coronary syndrome  (ISO)
Intestinal Reperfusion Injury  (ISO)
intracranial aneurysm  (ISO)
kidney disease  (ISO)
kidney failure  (ISO)
Kidney Reperfusion Injury  (ISO)
Left Ventricular Hypertrophy  (ISO)
leukemia  (ISO)
leukostasis  (ISO)
liver cirrhosis  (ISO)
Liver Metastasis  (IEP)
lung cancer  (ISO)
lung carcinoma  (ISO)
lung disease  (IAGP,IEP,ISO)
Lung Injury  (ISO)
Lung Neoplasms  (ISO)
malaria  (IMP)
male infertility  (ISO)
Memory Disorders  (ISO)
Meningococcal Infections  (ISO)
microcephaly  (ISO)
middle cerebral artery infarction  (ISO)
mitral valve disease  (ISO)
mitral valve prolapse  (ISO)
multiple myeloma  (ISO)
Mycobacterium Infections  (ISO)
myocardial infarction  (ISO)
myocarditis  (ISO)
Neoplasm Metastasis  (ISO)
nephritis  (ISO)
nephrosis  (ISO)
nephrotic syndrome  (ISO)
non-alcoholic fatty liver disease  (ISO)
non-arteritic anterior ischemic optic neuropathy  (ISO)
obesity  (ISO)
obstructive sleep apnea  (ISO)
ocular hypotension  (ISO)
osteoporosis  (ISO)
Pain  (ISO)
pancreatic cancer  (IMP)
pancreatic ductal carcinoma  (ISO)
Parkinson's disease  (ISO)
Peritoneal Fibrosis  (IMP,ISO)
Pleural Effusion  (ISO)
pneumonia  (ISO)
polycythemia  (ISO)
pre-eclampsia  (ISO)
pre-malignant neoplasm  (ISO)
Pregnancy-Induced Hypertension  (ISO)
Premature Infant Diseases  (ISO)
primary biliary cholangitis  (ISO)
Prostatic Neoplasms  (ISO)
proteinuria  (ISO)
pulmonary fibrosis  (IMP,ISO)
pulmonary hypertension  (ISO)
Puromycin Aminonucleoside Nephrosis  (ISO)
pyelonephritis  (ISO)
Radiation Nephropathy  (ISO)
renal fibrosis  (ISO)
Renal Tubular Dysgenesis  (ISO)
renovascular hypertension  (ISO)
Reperfusion Injury  (ISO)
respiratory system disease  (ISO)
Right Ventricular Hypertrophy  (ISO)
sarcoidosis  (ISO)
schizophrenia  (ISO)
Sepsis  (ISO)
severe acute respiratory syndrome  (ISO)
Staphylococcal Infections  (ISO)
stomach cancer  (ISO)
Stomach Neoplasms  (ISO)
Stroke  (ISO)
subacute sclerosing panencephalitis  (ISO)
substance-induced psychosis  (ISO)
Sudden Death  (ISO)
systemic lupus erythematosus  (ISO)
systemic scleroderma  (ISO)
toxic shock syndrome  (ISO)
type 1 diabetes mellitus  (ISO)
type 2 diabetes mellitus  (ISO)
ureteral obstruction  (ISO)
uveitis  (ISO)
Vascular System Injuries  (ISO)
Venous Thromboembolism  (ISO)
Ventricular Fibrillation  (ISO)
Ventricular Remodeling  (ISO)
viral pneumonia  (ISO)
Weight Gain  (ISO)
Weight Loss  (ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-pilocarpine  (ISO)
(+)-schisandrin B  (ISO)
(+)-trans-(S)-allethrin  (ISO)
(-)-epigallocatechin 3-gallate  (ISO)
(R)-lipoic acid  (EXP,ISO)
(S)-colchicine  (ISO)
(S)-nicotine  (ISO)
(S,S,S)-nicotianamine  (ISO)
1,10-phenanthroline  (ISO)
1,2-dimethylhydrazine  (EXP)
14,15-EET  (ISO)
17alpha-ethynylestradiol  (EXP)
17beta-estradiol  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (ISO)
3,3',5-triiodo-L-thyronine  (ISO)
3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione  (ISO)
3-chloropropane-1,2-diol  (ISO)
4,4'-sulfonyldiphenol  (EXP)
4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile  (ISO)
4-hydroxyphenyl retinamide  (EXP)
6-propyl-2-thiouracil  (ISO)
7,9-dihydro-1H-purine-2,6,8(3H)-trione  (EXP)
Ac-Ser-Asp-Lys-Pro-OH  (EXP)
acetamide  (ISO)
acetylsalicylic acid  (ISO)
acrylamide  (EXP)
actinomycin D  (ISO)
aldehydo-D-glucose  (EXP,ISO)
aldosterone  (ISO)
aluminium atom  (EXP)
aluminium(0)  (EXP)
aminoguanidine  (EXP)
amitrole  (ISO)
amlodipine  (ISO)
ammonium chloride  (ISO)
antirheumatic drug  (ISO)
arsenite(3-)  (EXP)
atorvastatin calcium  (ISO)
atrazine  (ISO)
benazepril  (ISO)
benzo[a]pyrene  (EXP,ISO)
beta-naphthoflavone  (ISO)
bezafibrate  (ISO)
bis(2-chloroethyl) sulfide  (ISO)
bisphenol A  (EXP,ISO)
bleomycin A2  (ISO)
boric acid  (ISO)
bortezomib  (ISO)
cadmium dichloride  (ISO)
caffeine  (ISO)
candesartan  (ISO)
cannabidiol  (ISO)
captan  (EXP)
captopril  (EXP,ISO)
carbon nanotube  (EXP)
carvedilol  (ISO)
chromium atom  (ISO)
chromium(6+)  (EXP)
cilazapril monohydrate  (ISO)
cobalt dichloride  (EXP)
cocaine  (ISO)
corticosterone  (ISO)
Cuprizon  (ISO)
curcumin  (ISO)
cyclophosphamide  (ISO)
D-glucose  (EXP,ISO)
DDT  (ISO)
dexamethasone  (EXP,ISO)
dextran sulfate  (EXP)
diisononyl phthalate  (EXP)
dioxygen  (EXP)
doxorubicin  (ISO)
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor  (ISO)
enalapril  (EXP,ISO)
enalaprilat dihydrate  (ISO)
ethanol  (ISO)
ethylbenzene  (ISO)
ethylenediaminetetraacetic acid  (ISO)
fenvalerate  (EXP)
flavonoids  (ISO)
folic acid  (EXP,ISO)
folpet  (EXP)
fructose  (ISO)
furan  (ISO)
genistein  (ISO)
gentamycin  (ISO)
glucose  (EXP,ISO)
glycidol  (ISO)
goralatide  (EXP)
GW 4064  (EXP)
herbimycin  (ISO)
hydralazine  (ISO)
hydrazines  (EXP)
hydrochlorothiazide  (ISO)
hydrogen peroxide  (EXP,ISO)
indometacin  (ISO)
indoxyl sulfate  (ISO)
ketamine  (ISO)
L-ascorbic acid  (ISO)
Lasiocarpine  (ISO)
lead diacetate  (ISO)
lead(0)  (ISO)
lead(2+)  (ISO)
lipoic acid  (EXP,ISO)
lisinopril dihydrate  (ISO)
lithium chloride  (ISO)
losartan  (EXP,ISO)
Magnolol  (ISO)
manganese(II) chloride  (ISO)
manidipine  (ISO)
methoxychlor  (ISO)
metoprolol  (ISO)
microcystin RR  (EXP)
mifepristone  (ISO)
monocrotaline  (ISO)
N(gamma)-nitro-L-arginine methyl ester  (ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
N-methylnicotinate  (EXP,ISO)
N-nitrosodiethylamine  (ISO)
Nandrolone decanoate  (ISO)
naringin  (ISO)
nicotianamine  (ISO)
nicotine  (ISO)
nicotinic acid  (ISO)
nitric oxide  (ISO)
nitrofen  (ISO)
NS-398  (ISO)
oltipraz  (EXP,ISO)
omapatrilat  (ISO)
ouabain  (ISO)
ozone  (EXP)
paracetamol  (EXP,ISO)
paraquat  (EXP,ISO)
perindopril  (ISO)
phenylephrine  (ISO)
phorbol 13-acetate 12-myristate  (ISO)
pioglitazone  (ISO)
pirfenidone  (ISO)
pirinixic acid  (EXP)
potassium dichromate  (EXP)
pravastatin  (ISO)
pregabalin  (ISO)
proanthocyanidin  (ISO)
prostaglandin E2  (ISO)
prostaglandin I2  (ISO)
quercetin  (EXP,ISO)
quinapril hydrochloride  (ISO)
raloxifene  (ISO)
ramipril  (ISO)
rebaudioside A  (ISO)
resveratrol  (EXP,ISO)
rivastigmine  (ISO)
silicon dioxide  (EXP)
silver atom  (ISO)
silver(0)  (ISO)
sodium arsenite  (EXP,ISO)
sodium chloride  (ISO)
sodium dichromate  (ISO)
sodium fluoride  (EXP)
spironolactone  (ISO)
steviol  (ISO)
stevioside  (ISO)
streptozocin  (EXP,ISO)
sunitinib  (ISO)
telmisartan  (ISO)
testosterone  (ISO)
tetrachloromethane  (ISO)
titanium dioxide  (EXP,ISO)
toluene  (ISO)
trandolapril  (ISO)
tributylstannane  (EXP)
triclosan  (ISO)
triptonide  (EXP)
tyrphostin AG 1478  (ISO)
valproic acid  (ISO)
valsartan  (ISO)
venlafaxine hydrochloride  (ISO)
vinclozolin  (ISO)
zinc atom  (ISO)
zinc sulfate  (ISO)
zinc(0)  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
aging  (ISO)
amyloid-beta metabolic process  (ISO)
angiogenesis involved in coronary vascular morphogenesis  (ISO)
angiotensin maturation  (IDA,IMP,ISO)
animal organ regeneration  (ISO)
arachidonic acid secretion  (ISO)
bradykinin catabolic process  (ISO)
brain development  (ISO)
cell proliferation in bone marrow  (IMP)
cellular response to aldosterone  (ISO)
cellular response to glucose stimulus  (ISO)
eating behavior  (ISO)
embryo development ending in birth or egg hatching  (ISO)
female pregnancy  (ISO)
heart contraction  (IMP)
hormone catabolic process  (IDA,ISO)
hormone metabolic process  (ISO)
kidney development  (IMP,ISO)
lung alveolus development  (ISO)
lung development  (ISO)
male gonad development  (IMP,ISO)
negative regulation of calcium ion import  (ISO)
negative regulation of gap junction assembly  (IMP)
negative regulation of gene expression  (IMP)
negative regulation of glucose import  (ISO)
negative regulation of protein binding  (IMP)
negative regulation of renal sodium excretion  (ISO)
neutrophil mediated immunity  (IMP)
peptide catabolic process  (ISO)
peptide metabolic process  (ISO)
positive regulation of apoptotic process  (ISO)
positive regulation of blood pressure  (ISO)
positive regulation of inflammatory response  (ISO)
positive regulation of neurogenesis  (ISO)
positive regulation of peptidyl-cysteine S-nitrosylation  (IMP)
positive regulation of peptidyl-tyrosine autophosphorylation  (IMP)
positive regulation of protein binding  (IMP)
positive regulation of protein tyrosine kinase activity  (IMP)
positive regulation of systemic arterial blood pressure  (IBA,IMP,ISO)
positive regulation of vasoconstriction  (ISO)
post-transcriptional regulation of gene expression  (IMP)
proteolysis  (IEA)
regulation of angiotensin metabolic process  (ISO)
regulation of blood pressure  (IDA,IMP,ISO)
regulation of hematopoietic stem cell proliferation  (IMP)
regulation of smooth muscle cell migration  (ISO)
regulation of synaptic plasticity  (IDA)
regulation of systemic arterial blood pressure by renin-angiotensin  (IBA,ISO)
response to dexamethasone  (ISO)
response to hypoxia  (ISO)
response to laminar fluid shear stress  (ISO)
response to lipopolysaccharide  (ISO)
response to nutrient levels  (ISO)
response to thyroid hormone  (ISO)
response to xenobiotic stimulus  (ISO)
sensory perception of pain  (ISO)
spermatogenesis  (IMP)
substance P catabolic process  (ISO)
vasoconstriction  (ISO)

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Mammalian Phenotype
abnormal angiotensin I-converting enzyme activity  (IAGP)
abnormal cardiovascular system physiology  (IAGP)
abnormal circulating angiotensinogen level  (IAGP)
abnormal circulating protein level  (IAGP)
abnormal embryo size  (IEA)
abnormal epididymal fat pad morphology  (IAGP)
abnormal homeostasis  (IAGP)
abnormal interleukin level  (IAGP)
abnormal kidney arterial blood vessel morphology  (IAGP)
abnormal kidney blood vessel morphology  (IAGP)
abnormal kidney cortex morphology  (IAGP)
abnormal kidney corticomedullary boundary morphology  (IAGP)
abnormal kidney medulla morphology  (IAGP)
abnormal kidney medullary ray morphology  (IAGP)
abnormal kidney morphology  (IAGP)
abnormal kidney papilla morphology  (IAGP)
abnormal kidney pelvis morphology  (IAGP)
abnormal renal artery morphology  (IAGP)
abnormal renal glomerulus morphology  (IAGP)
abnormal response/metabolism to endogenous compounds  (IAGP)
abnormal systemic arterial blood pressure  (IAGP)
abnormal tumor morphology  (IAGP)
abnormal urine homeostasis  (IAGP)
abnormal urine osmolality  (IAGP)
albuminuria  (IAGP)
atrial fibrillation  (IAGP)
decreased angiotensin I-converting enzyme activity  (IAGP)
decreased angiotensin II level  (IAGP)
decreased body weight  (IAGP)
decreased circulating angiotensin II level  (IAGP)
decreased circulating angiotensinogen level  (IAGP)
decreased fertilization frequency  (IAGP)
decreased heart rate  (IAGP)
decreased heart weight  (IAGP)
decreased hematocrit  (IAGP)
decreased insulin secretion  (IAGP)
decreased kidney weight  (IAGP)
decreased litter size  (IAGP)
decreased sensitivity to xenobiotic induced morbidity/mortality  (IAGP)
decreased survivor rate  (IAGP)
decreased susceptibility to injury  (IAGP)
decreased systemic arterial systolic blood pressure  (IAGP)
decreased tumor growth/size  (IAGP)
decreased urine aldosterone level  (IAGP)
decreased urine osmolality  (IAGP)
dilated heart  (IAGP)
dilated kidney calyx  (IAGP)
dilated renal glomerular capsule  (IAGP)
embryonic growth retardation  (IEA)
enlarged heart atrium  (IAGP)
hydronephrosis  (IAGP)
hyperactivity  (IEA)
hypotension  (IAGP)
impaired binding of sperm to zona pellucida  (IAGP)
impaired fertilization  (IAGP)
impaired sperm migration in female genital tract  (IAGP)
increased angiotensin I-converting enzyme activity  (IAGP)
increased blood urea nitrogen level  (IAGP)
increased body weight  (IAGP)
increased circulating creatinine level  (IAGP)
increased circulating renin level  (IAGP)
increased fluid intake  (IAGP)
increased food intake  (IAGP)
increased glomerular capsule space  (IAGP)
increased heart rate  (IAGP)
increased heart weight  (IAGP)
increased insulin secretion  (IAGP)
increased renin activity  (IAGP)
increased systemic arterial blood pressure  (IAGP)
increased T cell number  (IAGP)
increased urine potassium level  (IAGP)
kidney atrophy  (IAGP)
kidney cortex atrophy  (IAGP)
kidney cyst  (IAGP)
kidney inflammation  (IAGP)
kidney medulla atrophy  (IAGP)
kidney medulla cyst  (IAGP)
kidney medulla hypoplasia  (IAGP)
kidney papillary atrophy  (IAGP)
polyuria  (IAGP)
postnatal lethality, incomplete penetrance  (IAGP)
premature death  (IAGP)
preweaning lethality, complete penetrance  (IEA)
preweaning lethality, incomplete penetrance  (IAGP)
reduced male fertility  (IAGP)
renal tubule atrophy  (IAGP)
tubulointerstitial nephritis  (IAGP)
vascular inflammation  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage. Abdel-Wahab BA, etal., Chem Biol Interact. 2014 Jun 5;216:43-52. doi: 10.1016/j.cbi.2014.03.012. Epub 2014 Apr 5.
2. Mechanisms of angiotensin converting enzyme inhibitor-induced IOP reduction in normotensive rats. Agarwal R, etal., Eur J Pharmacol. 2014 May 5;730:8-13. doi: 10.1016/j.ejphar.2014.02.021. Epub 2014 Feb 26.
3. Is serum angiotensin converting enzyme level a useful non-invasive marker for liver fibrosis in patients with chronic hepatitis C? Akar T, Rev Assoc Med Bras (1992). 2018 Mar;64(3):224-229. doi: 10.1590/1806-9282.64.03.224.
4. Elevated serum angiotensin converting enzyme levels as a reflection of bone marrow renin-angiotensin system activation in multiple myeloma. Albayrak M, etal., J Renin Angiotensin Aldosterone Syst. 2012 Jun;13(2):259-64. doi: 10.1177/1470320312437070. Epub 2012 Feb 16.
5. Angiotensin-converting enzyme insertion/deletion gene polymorphism in patients with familial multiple cerebral cavernous malformations. Altas M, etal., J Clin Neurosci. 2010 Aug;17(8):1034-7. doi: 10.1016/j.jocn.2009.12.002. Epub 2010 May 21.
6. Effects of blockade of the renin-angiotensin and endothelin systems on experimental bronchiolitis obliterans. Antus B, etal., J Heart Lung Transplant. 2006 Nov;25(11):1324-9.
7. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. Arafat HA, etal., J Am Coll Surg. 2007 May;204(5):996-1005; discussion 1005-6.
8. Angiotensin I-converting enzyme activity in puromycin aminonucleoside-nephrotic syndrome. Arevalo AE, etal., Clin Chim Acta. 1990 Nov 5;191(3):175-84.
9. Angiotensin-converting enzyme genotype predicts valve damage in acute rheumatic fever. Atalar E, etal., J Heart Valve Dis. 2003 Jan;12(1):7-10.
10. Polymorphism of angiotensin converting enzyme is associated with severe circulatory compromise in febrile neutropenic children with cancer. Bardi E, etal., Pediatr Blood Cancer. 2005 Aug;45(2):217-21.
11. ACE activity is modulated by the enzyme a-galactosidase A. Batista EC, etal., J Mol Med (Berl). 2011 Jan;89(1):65-74. doi: 10.1007/s00109-010-0686-2. Epub 2010 Oct 13.
12. Effects on cytokines and histology by treatment with the ACE inhibitor captopril and the antioxidant retinoic acid in the monocrotaline model of experimentally induced lung fibrosis. Baybutt RC, etal., Curr Pharm Des. 2007;13(13):1327-33.
13. The genetic association database. Becker KG, etal., Nat Genet. 2004 May;36(5):431-2.
14. No contribution of angiotensin-converting enzyme (ACE) gene variants to severe obesity: a model for comprehensive case/control and quantitative cladistic analysis of ACE in human diseases. Bell CG, etal., Eur J Hum Genet. 2007 Mar;15(3):320-7. Epub 2006 Dec 13.
15. Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Benigni A, etal., Am J Pathol. 2011 Aug;179(2):628-38. doi: 10.1016/j.ajpath.2011.04.003. Epub 2011 Jun 2.
16. Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started. Benigni A, etal., Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10.
17. Elevated levels of circulating angiotensin converting enzyme in patients with hepatoportal sclerosis. Beyazit Y, etal., Dig Dis Sci. 2011 Jul;56(7):2160-5. doi: 10.1007/s10620-011-1580-7. Epub 2011 Feb 3.
18. Comparison of the incidence of imidapril and enalapril induced cough. Boonyapisit W and Tresukosol D, J Med Assoc Thai. 2010 Jan;93 Suppl 1:S48-53.
19. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Burchill L, etal., Exp Physiol. 2008 May;93(5):622-30. doi: 10.1113/expphysiol.2007.040386. Epub 2008 Jan 25.
20. Myocardial infarction increases ACE2 expression in rat and humans. Burrell LM, etal., Eur Heart J 2005 Feb;26(4):369-75; discussion 322-4. Epub 2005 Jan 25.
21. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension. Ceron CS, etal., Matrix Biol. 2012 May;31(4):261-70. Epub 2012 Feb 10.
22. Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats. Challah M, etal., Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):235-43.
23. Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension. Challah M, etal., Cardiovasc Res. 1995 Aug;30(2):231-9.
24. Role of angiotensin II in retinal leukostasis in the diabetic rat. Chen P, etal., Exp Eye Res. 2006 Nov;83(5):1041-51. Epub 2006 Jul 5.
25. Effect of angiotensin I-converting enzyme inhibitory peptide from rice dregs protein on antihypertensive activity in spontaneously hypertensive rats. Chen Q, etal., Asia Pac J Clin Nutr. 2007;16 Suppl:281-5.
26. Role of angiotensin-converting enzyme gene polymorphisms in children with sepsis and septic shock. Cogulu O, etal., Pediatr Int. 2008 Aug;50(4):477-80. doi: 10.1111/j.1442-200X.2008.02583.x.
27. Sex-specific effects of low protein diet on in utero programming of renal G-protein coupled receptors. Cooke CL, etal., J Dev Orig Health Dis. 2014 Feb;5(1):36-44. doi: 10.1017/S2040174413000524.
28. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Crackower MA, etal., Nature 2002 Jun 20;417(6891):822-8.
29. Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine. Cruz CI, etal., Am J Physiol Renal Physiol. 2000 Jan;278(1):F122-9.
30. Effects of E. coli endotoxin on rat plasma angiotensin converting enzyme activity in vitro and in vivo. Deitz DM, etal., Circ Shock. 1987;21(1):23-9.
31. COVID-19 infections are also affected by human ACE1 D/I polymorphism. Delanghe JR, etal., Clin Chem Lab Med. 2020 Jun 25;58(7):1125-1126. doi: 10.1515/cclm-2020-0425.
32. Association study of ACE and eNOS single nucleotide polymorphisms with Henoch-Schonlein purpura nephritis. Di B, etal., Mol Med Rep. 2012 Nov;6(5):1171-7. doi: 10.3892/mmr.2012.1032. Epub 2012 Aug 10.
33. Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study. Di Marco F, etal., Pulm Pharmacol Ther. 2010 Jun;23(3):159-64. Epub 2010 Jan 22.
34. Correlations between ACE single nucleotide polymorphisms and prognosis of patients with septic shock. Dou XM, etal., Biosci Rep. 2017 Apr 28;37(2). pii: BSR20170145. doi: 10.1042/BSR20170145. Print 2017 Apr 30.
35. Effect of valsartan versus lisinopril on peritoneal sclerosis in rats. Duman S, etal., Int J Artif Organs. 2005 Feb;28(2):156-63.
36. Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury. Efrati S, etal., Nephrol Dial Transplant. 2012 Jan;27(1):136-45. Epub 2011 Jun 16.
37. Angiotensin converting enzyme gene polymorphism in Turkish asthmatic patients. Eryuksel E, etal., J Asthma. 2009 May;46(4):335-8.
38. Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C. Fabris C, etal., Hepatol Res. 2009 Aug;39(8):795-804. doi: 10.1111/j.1872-034X.2009.00518.x. Epub 2009 Apr 23.
39. Hepatotoxicity effect of short-term Bradykinin potentiating factor in cholestatic rats. Fahmy SR, etal., Toxicol Lett. 2019 Feb;301:73-78. doi: 10.1016/j.toxlet.2018.11.006. Epub 2018 Nov 17.
40. Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Fatini C, etal., Blood Coagul Fibrinolysis. 2000 Oct;11(7):657-62.
41. AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients. Fatini C, etal., Int J Cardiol. 2008 Jan 24;123(3):293-7. Epub 2007 Mar 26.
42. Effects of curcumin on angiotensin-converting enzyme gene expression, oxidative stress and anti-oxidant status in thioacetamide-induced hepatotoxicity. Fazal Y, etal., J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):1046-51. doi: 10.1177/1470320314545777. Epub 2014 Aug 20.
43. The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Fendrich V, etal., Gut. 2010 May;59(5):630-7. Epub 2009 Nov 1.
44. Unexpected role of the human cytomegalovirus contribute to essential hypertension in the Kazakh Chinese population of Xinjiang. Feng Q, etal., Biosci Rep. 2018 Jun 27;38(3). pii: BSR20171522. doi: 10.1042/BSR20171522. Print 2018 Jun 29.
45. Genetic polymorphisms of the renin-angiotensin system in breast cancer patients. Fishchuk LE and Gorovenko NG, Exp Oncol. 2013 Jun;35(2):101-4.
46. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. Fogo A, etal., J Clin Invest. 1988 Jul;82(1):322-30.
47. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Fradin S, etal., Diabetes Metab. 2002 Feb;28(1):27-32.
48. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Fujisawa T, etal., Diabetes Care. 1995 Jul;18(7):983-5.
49. Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia. Gadelha A, etal., Psychiatry Res. 2015 Oct 30;229(3):702-7. doi: 10.1016/j.psychres.2015.08.018. Epub 2015 Aug 12.
50. [Effect of carvedilol and perindopril on Ca(2+) pump activity and Ca(2+)-release channel density in myocardial sarcoplasmic reticulum in rats with chronic heart failure following myocardial infarction] Geng ZH, etal., Nan Fang Yi Ke Da Xue Xue Bao. 2009 Jul;29(7):1461-4.
51. Risk of venous thromboembolism associated with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene. Gonzalez Ordonez AJ, etal., Blood Coagul Fibrinolysis. 2000 Jul;11(5):485-90.
52. Renin-angiotensin System Activation in Congenital Hepatic Fibrosis in the PCK Rat Model of Autosomal Recessive Polycystic Kidney Disease. Goto M, etal., J Pediatr Gastroenterol Nutr. 2010 Apr 14.
53. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease. Goto M, etal., Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27.
54. Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848). Gross V, etal., J Hepatol. 1993 Jan;17(1):40-7. doi: 10.1016/s0168-8278(05)80519-7.
55. Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Grosser M, etal., Sarcoidosis Vasc Diffuse Lung Dis. 2005 Mar;22(1):66-74.
56. Association between renin-angiotensin system gene polymorphism and recurrent wheezing in Chinese children: a 4-year follow-up study. Guo S, etal., J Int Med Res. 2009 Mar-Apr;37(2):351-8.
57. Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Hagiwara S, etal., Crit Care Med. 2009 Feb;37(2):626-33.
58. I/D ACE gene polymorphism in survival of leukemia patients -- hypothesis and pilot study. Hajek D, etal., Med Hypotheses. 2003 Jul;61(1):80-5.
59. [Increase of activity of angiotensin-converting enzyme in insulin-dependent diabetic patients with permanent microalbuminuria]. Hallab M, etal., Arch Mal Coeur Vaiss. 1992 Aug;85(8):1185-8.
60. Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral perfusion reserve in patients with previous minor stroke. Hatazawa J, etal., Stroke. 2004 Sep;35(9):2117-22. doi: 10.1161/01.STR.0000136034.86144.e9. Epub 2004 Jul 15.
61. Attenuation in rat brain nitric oxide synthase activity in the coarctation model of hypertension. Hegde LG, etal., Pharmacol Res. 1997 Aug;36(2):109-14.
62. Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. Herath CB, etal., Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G98-G106. Epub 2009 Apr 23.
63. The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes. Hibberd ML, etal., J Diabetes Complications. 1997 Jan-Feb;11(1):2-8.
64. Association of 3 gene polymorphisms with atopic diseases. Holla L, etal., J Allergy Clin Immunol. 1999 Apr;103(4):702-8.
65. Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease. Hou DR, etal., Chin Med J (Engl). 2008 Nov 20;121(22):2320-3.
66. ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions. Hsieh WY, etal., Int J Biol Sci. 2012;8(8):1197-205. doi: 10.7150/ijbs.5087. Epub 2012 Oct 17.
67. BML-111 equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis to protect hepatic fibrosis in rats. Hu Q, etal., Prostaglandins Other Lipid Mediat. 2017 Jul;131:75-82. doi: 10.1016/j.prostaglandins.2017.08.008. Epub 2017 Aug 16.
68. Expression of angiotensin-converting enzyme 2 in CCL4-induced rat liver fibrosis. Huang Q, etal., Int J Mol Med. 2009 Jun;23(6):717-23. doi: 10.3892/ijmm_00000185.
69. [Expression and correlation of angiotensin-converting enzyme 2 in CCl4-induced rat liver fibrosis]. Huang Q, etal., Zhonghua Gan Zang Bing Za Zhi. 2013 Jan;21(1):47-52. doi: 10.3760/cma.j.issn.1007-3418.2013.01.013.
70. Effect of Antiviral Therapy on Serum Activity of Angiotensin Converting Enzyme in Patients with Chronic Hepatitis C. Husic-Selimovic A, etal., Med Arch. 2016 Apr;70(2):92-6. doi: 10.5455/medarh.2016.70.92-96. Epub 2016 Apr 1.
71. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet. Imai E, etal., Clin Exp Nephrol. 2003 Jun;7(2):113-9.
72. Significant association between insertion/deletion polymorphism of the angiotensin-convertig enzyme gene and ankylosing spondylitis. Inanir A, etal., Mol Vis. 2012;18:2107-13. Epub 2012 Jul 26.
73. Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance. Ismael MA, etal., Eur J Pharmacol. 2008 Jul 28;589(1-3):66-72. Epub 2008 May 16.
74. Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease. Jia G, etal., Pediatr Nephrol. 2010 Jun;25(6):1139-46. Epub 2010 Mar 13.
75. Activation of the renin-angiotensin system in hyperoxia-induced lung fibrosis in neonatal rats. Jiang JS, etal., Neonatology. 2012;101(1):47-54. doi: 10.1159/000329451. Epub 2011 Jul 26.
76. Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines. Kang YM, etal., Toxicol Appl Pharmacol. 2014 Feb 1;274(3):436-44. doi: 10.1016/j.taap.2013.12.001. Epub 2013 Dec 14.
77. Effect of lisinopril on renal tissue damage in unilateral ureteral obstruction in rats. Karabuga I, etal., Urol Res. 2012 Feb;40(1):27-34. doi: 10.1007/s00240-011-0393-7. Epub 2011 Jun 11.
78. Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. Karram T, etal., Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1351-8. Epub 2005 May 13.
79. Functional annotation of a full-length mouse cDNA collection. Kawai J, etal., Nature. 2001 Feb 8;409(6821):685-90.
80. Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients. Kedzierska K, etal., Clin Transplant. 2008 Mar-Apr;22(2):156-61. doi: 10.1111/j.1399-0012.2007.00760.x.
81. Association between polymorphisms of the angiotensin-converting enzyme and angiotensinogen genes and allergic rhinitis in a Korean population. Kim JJ, etal., Ann Otol Rhinol Laryngol. 2004 Apr;113(4):297-302.
82. Preventive effects of the angiotensin-converting enzyme inhibitor, captopril, on the development of azoxymethane-induced colonic preneoplastic lesions in diabetic and hypertensive rats. Kochi T, etal., Oncol Lett. 2014 Jul;8(1):223-229. Epub 2014 May 12.
83. Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat. Kohara K, etal., Hypertension. 1993 Jun;21(6 Pt 2):975-9.
84. Reciprocal interactions of obstructive sleep apnea and hypertension associated with ACE I/D polymorphism in males. Koyama RG, etal., Sleep Med. 2009 Dec;10(10):1107-11. Epub 2009 May 23.
85. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population. Kulah E, etal., Blood Press Monit. 2007 Aug;12(4):207-13.
86. Perinatal DDT Exposure Induces Hypertension and Cardiac Hypertrophy in Adult Mice. La Merrill MA, etal., Environ Health Perspect. 2016 Nov;124(11):1722-1727. doi: 10.1289/EHP164. Epub 2016 Jun 21.
87. Disease marker combination enhances patient characterization in the Finnish sarcoidosis patients. Lahtela E, etal., Respir Med. 2017 Nov;132:92-94. doi: 10.1016/j.rmed.2017.09.014. Epub 2017 Oct 3.
88. Association of angiotensin converting enzyme and angiotensin type 2 receptor gene polymorphisms with renal damage in posterior urethral valves. Laksmi NK, etal., J Pediatr Urol. 2010 Dec;6(6):560-6. Epub 2010 Feb 10.
89. Upregulation of a local renin-angiotensin system in the rat carotid body during chronic intermittent hypoxia. Lam SY, etal., Exp Physiol. 2014 Jan;99(1):220-31. doi: 10.1113/expphysiol.2013.074591. Epub 2013 Sep 13.
90. Targeting the renin-angiotensin system: what's new? Leckie BJ Curr Med Chem Cardiovasc Hematol Agents. 2005 Jan;3(1):23-32.
91. [Serum angiotensin converting enzyme activity in sarcoidosis. A review of seventy cases]. Leclerc P, etal., Sem Hop. 1982 May 27;58(21):1291-4.
92. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice. Lee C, etal., Life Sci. 2014 Jan 24;95(1):29-39. doi: 10.1016/j.lfs.2013.11.005. Epub 2013 Nov 15.
93. Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. Leshem-Rubinow E, etal., Mayo Clin Proc. 2012 Dec;87(12):1189-95. doi: 10.1016/j.mayocp.2012.07.020. Epub 2012 Nov 7.
94. Angiotensin-Converting Enzyme N-Terminal Inactivation Alleviates Bleomycin-Induced Lung Injury. Li P, etal., Am J Pathol. 2010 Jul 22.
95. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl4-Induced Hepatic Fibrosis. Li XY, etal., Chin J Integr Med. 2018 Nov;24(11):853-859. doi: 10.1007/s11655-017-2909-7. Epub 2018 Jan 15.
96. Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population. Liang S, etal., Mol Biol Rep. 2013 Jan;40(1):463-8. doi: 10.1007/s11033-012-2081-2. Epub 2012 Oct 13.
97. Inhibition of beta-myosin heavy chain gene expression in pressure overload rat heart by losartan and captopril. Ling Q, etal., Zhongguo Yao Li Xue Bao. 1997 Jan;18(1):63-6.
98. Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis. Liu J, etal., Life Sci. 2018 Sep 1;208:139-148. doi: 10.1016/j.lfs.2018.07.013. Epub 2018 Jul 7.
99. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Macconi D, etal., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22.
100. Renin-angiotensin-aldosterone system genes and nonarteritic anterior ischemic optic neuropathy. Markoula S, etal., Mol Vis. 2011;17:1254-60. Epub 2011 May 6.
101. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Marre M, etal., Diabetes. 1994 Mar;43(3):384-8.
102. Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy. Matsumoto A, etal., Diabetes Res Clin Pract. 2000 Dec;50(3):195-202.
103. Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat. Matus M, etal., Mol Cell Biochem. 2015 May;403(1-2):199-208. doi: 10.1007/s11010-015-2350-1. Epub 2015 Feb 8.
104. Angiotensin-converting enzyme in non-neoplastic kidney diseases. Metzger R, etal., Kidney Int. 1999 Oct;56(4):1442-54.
105. Electronic Transfer of Homolog Data MGD and Homologene mouse data transfer
106. MGDs mouse GO annotations MGD data from the GO Consortium
107. MGD IEA MGD IEA
108. Elevated serum levels of angiotensin-converting enzyme in patients with diabetic retinopathy. Migdalis IN, etal., South Med J. 1990 Apr;83(4):425-7.
109. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Molteni A, etal., Curr Pharm Des. 2007;13(13):1307-16.
110. Renal ACE and ACE2 expression in early diabetic rats. Moon JY, etal., Nephron Exp Nephrol. 2008;110(1):e8-e16. Epub 2008 Aug 4.
111. The kallikrein-kinin system: current and future pharmacological targets. Moreau ME, etal., J Pharmacol Sci. 2005 Sep;99(1):6-38.
112. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Mortensen EM, etal., Respir Res. 2009 Jun 3;10:45.
113. Is angiotensin I-converting enzyme a "master" disease gene? Moskowitz DW, Diabetes Technol Ther. 2002;4(5):683-711. doi: 10.1089/152091502320798321.
114. Upregulation of Th1 cytokine profile in bronchoalveolar lavage fluid of patients with hypersensitivity pneumonitis. Mroz RM, etal., J Physiol Pharmacol. 2008 Dec;59 Suppl 6:499-505.
115. Antihypertensive medications and risk of community-acquired pneumonia. Mukamal KJ, etal., J Hypertens. 2010 Feb;28(2):401-5.
116. Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction. Murca TM, etal., Regul Pept. 2012 Aug 20;177(1-3):107-15. doi: 10.1016/j.regpep.2012.05.093. Epub 2012 May 14.
117. The impact of statins, ACE inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort. Myles PR, etal., Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):697-703.
118. The impact of host's genetic susceptibility on Helicobacter pylori infection in children. Mărginean MO, etal., Medicine (Baltimore). 2017 Jul;96(30):e7612. doi: 10.1097/MD.0000000000007612.
119. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey. Nacak M, etal., Cancer Genet Cytogenet. 2010 Apr 1;198(1):22-6.
120. Evidence for the involvement of NADPH oxidase in ischemia/reperfusion-induced gastric damage via angiotensin II. Nakagiri A, etal., J Physiol Pharmacol. 2010 Apr;61(2):171-9.
121. Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis. Nakaya H, etal., Hypertens Res. 1999 Nov;22(4):303-12.
122. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Nakhoul F, etal., Am J Physiol Renal Physiol. 2005 Oct;289(4):F880-90. Epub 2005 Jun 7.
123. Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats. Nambu K, etal., Arzneimittelforschung. 1986;36(1):47-51.
124. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases. Neo JH, etal., BMC Cancer. 2010 Apr 10;10:134. doi: 10.1186/1471-2407-10-134.
125. Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component. Neri Serneri GG, etal., Circ Res. 2004 Jun 25;94(12):1630-7. Epub 2004 May 6.
126. Activation of cardiac renin-angiotensin system in unstable angina. Neri Serneri GG, etal., J Am Coll Cardiol. 2001 Jul;38(1):49-55.
127. ACE2 and ANG-(1-7) in the rat uterus during early and late gestation. Neves LA, etal., Am J Physiol Regul Integr Comp Physiol. 2008 Jan;294(1):R151-61. Epub 2007 Oct 31.
128. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B. Noguchi R, etal., World J Gastroenterol. 2017 Sep 28;23(36):6705-6714. doi: 10.3748/wjg.v23.i36.6705.
129. Isoproterenol and angiotensin I-converting enzyme in lung, left ventricle, and plasma during myocardial hypertrophy and fibrosis. Ocaranza MP, etal., J Cardiovasc Pharmacol. 2002 Aug;40(2):246-54.
130. Insertion/deletion polymorphism and serum activity of the angiotensin-converting enzyme in Turkish patients with obstructive sleep apnea syndrome. Ogus C, etal., Biochem Genet. 2010 Jun;48(5-6):516-23. Epub 2010 Feb 25.
131. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Ohkubo T, etal., Am J Respir Crit Care Med. 2004 May 1;169(9):1041-5. Epub 2004 Feb 27.
132. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Oikawa T, etal., Kidney Int. 1997 Jan;51(1):164-72.
133. Lisinopril reduces cardiac hypertrophy and mortality in rats with aortocaval fistula. Oka T, etal., Eur J Pharmacol. 1993 Mar 30;234(1):55-60.
134. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73.
135. Antenatal glucocorticoid therapy suppresses angiotensin-converting enzyme activity in rats with nitrofen-induced congenital diaphragmatic hernia. Okoye BO, etal., J Pediatr Surg. 1998 Feb;33(2):286-91.
136. Mild but prolonged elevation of serum angiotensin converting enzyme (ACE) activity in alcoholics. Okuno F, etal., Alcohol. 1986 Nov-Dec;3(6):357-9. doi: 10.1016/0741-8329(86)90053-4.
137. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
138. The renin-angiotensin system genetic polymorphisms and rheumatic mitral valve disease. Ozisik K, etal., J Heart Valve Dis. 2004 Jan;13(1):33-7.
139. Angiotensin-converting enzyme gene polymorphism in Behcet's disease. Ozturk MA, etal., Clin Rheumatol. 2004 Apr;23(2):142-6. Epub 2004 Feb 24.
140. Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease. Pabst S, etal., Eur J Med Res. 2009 Dec 7;14 Suppl 4:177-81.
141. Enalapril attenuates ischaemic brain oedema and protects the blood-brain barrier in rats via an anti-oxidant action. Panahpour H, etal., Clin Exp Pharmacol Physiol. 2014 Mar;41(3):220-6. doi: 10.1111/1440-1681.12210.
142. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Park HC, etal., Yonsei Med J. 2005 Dec 31;46(6):779-87.
143. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size. Parlakpinar H, etal., Cytokine. 2011 Dec;56(3):688-94. Epub 2011 Oct 4.
144. Gene polymorphisms and febrile neutropenia in acute leukemia--no association with IL-4, CCR-5, IL-1RA, but the MBL-2, ACE, and TLR-4 are associated with the disease in Turkish patients: a preliminary study. Pehlivan M, etal., Genet Test Mol Biomarkers. 2014 Jul;18(7):474-81. doi: 10.1089/gtmb.2014.0004. Epub 2014 May 12.
145. Reduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control. Pignone A, etal., Ann Rheum Dis. 2007 Oct;66(10):1305-10. Epub 2007 Mar 14.
146. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
147. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
148. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Qi Y, etal., Hypertension. 2013 Oct;62(4):746-52. doi: 10.1161/HYPERTENSIONAHA.113.01337. Epub 2013 Aug 19.
149. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases Qiu QM, etal., Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2010 Apr;28(4):275-9.
150. Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease. Raizada V, etal., Kidney Int. 2005 Sep;68(3):1186-9.
151. Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells. Ramos P, etal., Respir Res. 2014 Apr 28;15:54. doi: 10.1186/1465-9921-15-54.
152. [Angiotensin converting enzyme and left ventricular hypertrophy in uremic patients: correlation and therapeutic options]. Rasic S, etal., Acta Med Croatica. 2004;58(3):193-6.
153. Mouse MP Annotation Import Pipeline RGD automated import pipeline
154. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
155. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
156. Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. Riaz AA, etal., FASEB J. 2004 May;18(7):881-3. doi: 10.1096/fj.03-0502fje. Epub 2004 Mar 4.
157. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Rice GI, etal., Biochem J. 2004 Oct 1;383(Pt 1):45-51.
158. Angiotensin-converting enzyme 2 (ACE2) and ACE activities display tissue-specific sensitivity to undernutrition-programmed hypertension in the adult rat. Riviere G, etal., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3.
159. Inhibitory effect of alphaS1- and alphaS2-casein hydrolysates on angiotensin I-converting enzyme in human endothelial cells in vitro, rat aortic tissue ex vivo, and renovascular hypertensive rats in vivo. Rousseau-Ralliard D, etal., J Dairy Sci. 2010 Jul;93(7):2906-21. doi: 10.3168/jds.2010-3060.
160. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection. Saadat M, Clin Chem Lab Med. 2020 Jun 25;58(7):1127-1128. doi: 10.1515/cclm-2020-0577.
161. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers. Sakuta T, etal., Arthritis Rheum. 2010 May;62(5):1319-28.
162. Local corticosterone production and angiotensin-I converting enzyme shedding in a mouse model of intestinal inflammation. Salmenkari H, etal., World J Gastroenterol. 2015 Sep 21;21(35):10072-9. doi: 10.3748/wjg.v21.i35.10072.
163. An experimental model of encapsulating peritoneal sclerosis. Sawada T, etal., Perit Dial Int. 2009 Feb;29 Suppl 2:S49-50.
164. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia. Sayitoglu M, etal., J Int Med Res. 2009 Jul-Aug;37(4):1018-28.
165. Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. Schürmann M, etal., J Intern Med. 2001 Jan;249(1):77-83. doi: 10.1046/j.1365-2796.2001.00776.x.
166. Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: Susceptibility and complications. Settin A, etal., J Renin Angiotensin Aldosterone Syst. 2014 Jan 22.
167. Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats. Shahid SM, etal., Pak J Pharm Sci. 2013 Sep;26(5):853-7.
168. The ACE2/Ang-(1-7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension. Shenoy V, etal., Am J Respir Crit Care Med. 2010 Jun 25.
169. Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats. Shimizu H, etal., Hypertens Res. 2009 Sep;32(9):786-90. Epub 2009 Jul 10.
170. Preparation and antagonistic effect of ACE inhibitory peptide from cashew. Shu Y, etal., J Sci Food Agric. 2019 Dec;99(15):6822-6832. doi: 10.1002/jsfa.9967. Epub 2019 Sep 18.
171. Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: clinical and possible pathogenic significance. Silverstein E, etal., Ann N Y Acad Sci. 1976;278:498-513. doi: 10.1111/j.1749-6632.1976.tb47062.x.
172. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Spencer AU, etal., Dig Dis Sci. 2007 Apr;52(4):1060-70. doi: 10.1007/s10620-006-9124-2. Epub 2007 Mar 7.
173. Angiotensin I-Converting Enzyme Insertion/Deletion Polymorphism and Increased Risk of Gall Bladder Cancer in Women. Srivastava K, etal., DNA Cell Biol. 2010 May 3.
174. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. Staessen JA, etal., J Hypertens. 1997 Dec;15(12 Pt 2):1579-92.
175. Statins and Angiotensin-Converting Enzyme Inhibitors are Associated with Reduced Mortality and Morbidity in Chronic Liver Disease. Stokkeland K, etal., Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):104-110. doi: 10.1111/bcpt.12844. Epub 2017 Jul 30.
176. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Sugimoto M, etal., Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1929-34. doi: 10.1158/1055-9965.EPI-06-0339.
177. ACE-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats. Sun HL, etal., Exp Clin Endocrinol Diabetes. 2009 Jul;117(7):336-44. Epub 2009 Mar 19.
178. Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischaemic stroke. Szolnoki Z, etal., J Neurol. 2001 Sep;248(9):756-61.
179. Angiotensin converting enzyme genotype affects development and course of sarcoidosis in Asian Indians. Tahir M, etal., Sarcoidosis Vasc Diffuse Lung Dis. 2007 Sep;24(2):106-12.
180. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Tarnow L, etal., Diabetes. 1995 May;44(5):489-94.
181. The restoration of kidney mitochondria function by inhibition of angiotensin-II production in rats with acute adriamycin-induced nephrotoxicity. Taskin E, etal., Ren Fail. 2014 May;36(4):606-12. doi: 10.3109/0886022X.2014.882737. Epub 2014 Feb 6.
182. Angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms in children with subacute sclerosing panencephalitis. Taşdemir N, etal., Am J Med Genet B Neuropsychiatr Genet. 2006 Jul 5;141B(5):445-8. doi: 10.1002/ajmg.b.30343.
183. Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. Thoene-Reineke C, etal., PLoS One. 2011;6(8):e23646. Epub 2011 Aug 25.
184. Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats. Tota S, etal., Behav Brain Res. 2012 Jan 1;226(1):317-30. Epub 2011 Aug 16.
185. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. Tseng CT, etal., J Virol. 2007 Feb;81(3):1162-73. Epub 2006 Nov 15.
186. Angiotensin-converting enzyme I/D polymorphism in Behcet's disease. Turgut S, etal., Med Princ Pract. 2005 Jul-Aug;14(4):213-6.
187. Angiotensin-converting enzyme gene polymorphism (insertion/deletion) and liver fibrosis in Turkish patients from the western Black Sea region, Turkey. Turhan NK, etal., Genet Mol Res. 2015 Dec 16;14(4):17079-90. doi: 10.4238/2015.December.16.8.
188. Polymorphisms of the angiotensin converting enzyme gene in early-onset and late-onset pre-eclampsia. Uma R, etal., J Matern Fetal Neonatal Med. 2010 Aug;23(8):874-9. doi: 10.3109/14767050903456667.
189. Upregulation of caveolin-1 expression is associated with structural modifications of endothelial cells in diabetic lung. Uyy E, etal., Microvasc Res. 2010 Mar;79(2):154-9. Epub 2010 Jan 6.
190. Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia. van de Garde EM, etal., Clin Chem Lab Med. 2007;45(10):1326-31.
191. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. van Ittersum FJ, etal., Nephrol Dial Transplant. 2000 Jul;15(7):1000-7.
192. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat. Velkoska E, etal., Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):49-55. Epub 2009 Apr 9.
193. Angiotensin I converting enzyme activity in adriamycin induced nephrosis in rats. Venkatesan N, etal., Toxicology. 1993 Dec 31;85(2-3):137-48.
194. Malaria infection promotes a selective expression of kinin receptors in murine liver. Ventura PDS, etal., Malar J. 2019 Jun 24;18(1):213. doi: 10.1186/s12936-019-2846-3.
195. [Role of angiotensin II type 1 receptor in activation of nuclear factor-kappaB and activator protein-1 in lung of mice with acute lung injury]. Wang F, etal., Zhonghua Shao Shang Za Zhi. 2010 Apr;26(2):113-6.
196. Expression of ACE and ACE2 in patients with hypertensive nephrosclerosis. Wang G, etal., Kidney Blood Press Res. 2011;34(3):141-9. doi: 10.1159/000324521. Epub 2011 Feb 24.
197. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats. Wang JL, etal., Kidney Int. 2000 Jun;57(6):2334-42.
198. [An experimental study of expression of angiotension converting enzyme 2 in myocardium and effect of telmisartan treatment in pressure-overloaded rats]. Wang LJ, etal., Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Apr;20(4):218-22.
199. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Wapstra FH, etal., Clin Sci (Lond). 1996 May;90(5):393-401.
200. ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling. Watanabe H, etal., Heart Rhythm. 2009 Sep;6(9):1327-32. doi: 10.1016/j.hrthm.2009.05.014. Epub 2009 May 15.
201. Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss. Wei CC, etal., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29.
202. Angiotensin-converting enzyme in sarcoid uveitis. Weinreb RN, etal., Invest Ophthalmol Vis Sci. 1979 Dec;18(12):1285-7.
203. Renin-angiotensin system gene polymorphisms and diastolic heart failure. Wu CK, etal., Eur J Clin Invest. 2008 Nov;38(11):789-97. doi: 10.1111/j.1365-2362.2008.02017.x.
204. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure. Wu CK, etal., Pharmacogenomics J. 2010 Feb;10(1):46-53. doi: 10.1038/tpj.2009.39. Epub 2009 Sep 15.
205. Inhibition of AAA in a rat model by treatment with ACEI perindopril. Xiong F, etal., J Surg Res. 2014 Jun 1;189(1):166-73. doi: 10.1016/j.jss.2014.01.057. Epub 2014 Feb 5.
206. Lack of association of polymorphisms of the angiotensin converting enzyme and angiotensinogen genes with nonfamilial hypertrophic or dilated cardiomyopathy. Yamada Y, etal., Am J Hypertens. 1997 Aug;10(8):921-8.
207. Beneficial effects of beta-conglycinin on renal function and nephrin expression in early streptozotocin-induced diabetic nephropathy rats. Yang HY, etal., Br J Nutr. 2014 Jan 14;111(1):78-85. doi: 10.1017/S0007114513001876. Epub 2013 Jun 27.
208. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. Yaren A, etal., Exp Biol Med (Maywood). 2008 Jan;233(1):32-7.
209. Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats. Yazawa H, etal., J Card Fail. 2011 Dec;17(12):1041-50. Epub 2011 Oct 17.
210. Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis. Ye S, etal., Heart. 2003 Oct;89(10):1195-9.
211. The role of IL-4 gene 70 bp VNTR and ACE gene I/D variants in Familial Mediterranean fever. Yigit S, etal., Cytokine. 2014 May;67(1):1-6. doi: 10.1016/j.cyto.2014.01.007. Epub 2014 Feb 22.
212. Interdependent effect of angiotensin-converting enzyme and platelet-activating factor acetylhydrolase gene polymorphisms on the progression of immunoglobulin A nephropathy. Yoon HJ, etal., Clin Genet. 2002 Aug;62(2):128-34.
213. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure. Yoshida J, etal., Hypertension. 2004 Mar;43(3):686-91. doi: 10.1161/01.HYP.0000118017.02160.fa. Epub 2004 Feb 2.
214. Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C. Yoshiji H, etal., World J Gastroenterol. 2006 Nov 14;12(42):6786-91. doi: 10.3748/wjg.v12.i42.6786.
215. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schonlein purpura nephritis. Yoshioka T, etal., Arch Dis Child. 1998 Nov;79(5):394-9.
216. Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population. Zha Y, etal., J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):695-9. doi: 10.1177/1470320314539829. Epub 2014 Sep 10.
217. Interaction of angiotensin I-converting enzyme insertion-deletion polymorphism and daily salt intake influences hypertension in Japanese men. Zhang L, etal., Hypertens Res. 2006 Oct;29(10):751-8.
218. Association of angiotensin-converting enzyme gene I/D and CYP11B2 gene -344T/C polymorphisms with lone atrial fibrillation and its recurrence after catheter ablation. Zhang XL, etal., Exp Ther Med. 2012 Oct;4(4):741-747. Epub 2012 Jul 31.
219. Angiotensin-converting enzyme gene insertion/deletion polymorphism in children with Henoch-Schonlein purpua nephritis. Zhou J, etal., J Huazhong Univ Sci Technolog Med Sci. 2004;24(2):158-61.
Additional References at PubMed
PMID:1328889   PMID:1651914   PMID:2157425   PMID:2164636   PMID:2545691   PMID:2835538   PMID:2841312   PMID:7671305   PMID:7753170   PMID:8025157   PMID:8391328   PMID:8598926  
PMID:8642790   PMID:8952516   PMID:9039095   PMID:9153279   PMID:9231832   PMID:9316207   PMID:9482924   PMID:9664078   PMID:9860346   PMID:9876285   PMID:9973259   PMID:10076178  
PMID:10187843   PMID:10330057   PMID:10349636   PMID:10405217   PMID:10589702   PMID:10720939   PMID:10775573   PMID:10831599   PMID:11042159   PMID:11076861   PMID:11104792   PMID:11303049  
PMID:11687636   PMID:11723129   PMID:11786523   PMID:11847186   PMID:12003835   PMID:12062093   PMID:12167603   PMID:12204286   PMID:12359984   PMID:12372418   PMID:12384478   PMID:12444051  
PMID:12459519   PMID:12477932   PMID:12574101   PMID:12620918   PMID:12637363   PMID:12646655   PMID:12691672   PMID:12777443   PMID:14525797   PMID:14757757   PMID:14769811   PMID:14981053  
PMID:15031129   PMID:15123520   PMID:15151931   PMID:15252021   PMID:15331425   PMID:15485659   PMID:15489334   PMID:15494545   PMID:15522949   PMID:15569856   PMID:15665832   PMID:15854741  
PMID:15947253   PMID:16001071   PMID:16141072   PMID:16141073   PMID:16154999   PMID:16186248   PMID:16215678   PMID:16221869   PMID:16270063   PMID:16547111   PMID:16585392   PMID:16602821  
PMID:16804085   PMID:16857898   PMID:16870943   PMID:16912050   PMID:16926271   PMID:16926272   PMID:16944957   PMID:17082641   PMID:17135368   PMID:17188239   PMID:17307998   PMID:17337599  
PMID:17525278   PMID:17566078   PMID:17634445   PMID:17652370   PMID:17656683   PMID:17892857   PMID:18032521   PMID:18084722   PMID:18158355   PMID:18192335   PMID:18212275   PMID:18252713  
PMID:18263657   PMID:18287559   PMID:18347228   PMID:18356559   PMID:18443281   PMID:18483182   PMID:18483625   PMID:18554416   PMID:19004932   PMID:19075090   PMID:19125280   PMID:19258495  
PMID:19556720   PMID:19673938   PMID:19706421   PMID:19710239   PMID:19782130   PMID:19846569   PMID:19880118   PMID:19930431   PMID:20012594   PMID:20030584   PMID:20116413   PMID:20530543  
PMID:20614101   PMID:20667972   PMID:20937811   PMID:21115616   PMID:21116821   PMID:21148418   PMID:21267068   PMID:21386911   PMID:21622682   PMID:21677750   PMID:21873635   PMID:21964607  
PMID:22203735   PMID:22580272   PMID:22999937   PMID:23055941   PMID:23535237   PMID:23619363   PMID:23633567   PMID:23846498   PMID:24194600   PMID:24414175   PMID:24475296   PMID:24487585  
PMID:24501175   PMID:24614194   PMID:24800825   PMID:24952961   PMID:25012170   PMID:25017399   PMID:25249154   PMID:25273883   PMID:25924878   PMID:26442284   PMID:27055902   PMID:27601681  
PMID:27879415   PMID:27880904   PMID:27988209   PMID:28273875   PMID:28390948   PMID:28394320   PMID:28515091   PMID:28665931   PMID:28935757   PMID:29101168   PMID:29187372   PMID:29549541  
PMID:29684311   PMID:29750573   PMID:29884907   PMID:30088535   PMID:30185469   PMID:30670595   PMID:31345929   PMID:31455729   PMID:31615657   PMID:31794021   PMID:31871049   PMID:32238693  
PMID:32325033   PMID:32669323   PMID:33480126   PMID:33781839   PMID:34517413   PMID:35201898   PMID:35364055  


Genomics

Comparative Map Data
Ace
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm3911105,858,774 - 105,880,790 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl11105,858,771 - 105,880,790 (+)EnsemblGRCm39 Ensembl
GRCm3811105,967,948 - 105,989,964 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl11105,967,945 - 105,989,964 (+)EnsemblGRCm38mm10GRCm38
MGSCv3711105,829,261 - 105,851,259 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv3611105,784,049 - 105,805,350 (+)NCBIMGSCv36mm8
Celera11117,699,475 - 117,721,491 (+)NCBICelera
Cytogenetic Map11E1NCBI
cM Map1168.84NCBI
ACE
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381763,477,061 - 63,498,373 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl1763,477,061 - 63,498,380 (+)EnsemblGRCh38hg38GRCh38
GRCh371761,554,422 - 61,575,734 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361758,908,166 - 58,928,711 (+)NCBINCBI36Build 36hg18NCBI36
Build 341758,915,908 - 58,952,935NCBI
Celera1755,942,475 - 55,963,778 (+)NCBICelera
Cytogenetic Map17q23.3NCBI
HuRef1756,922,781 - 56,944,100 (+)NCBIHuRef
CHM1_11761,618,550 - 61,639,869 (+)NCBICHM1_1
T2T-CHM13v2.01764,347,269 - 64,368,872 (+)NCBIT2T-CHM13v2.0
Ace
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.21090,910,316 - 90,930,437 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1090,910,316 - 90,931,131 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1095,964,627 - 95,984,783 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.01095,427,801 - 95,447,951 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.01090,839,016 - 90,859,102 (+)NCBIRnor_WKY
Rnor_6.01094,170,766 - 94,213,831 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1094,170,766 - 94,187,822 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01093,922,062 - 93,965,127 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41095,361,338 - 95,381,455 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
Celera1089,588,544 - 89,608,666 (+)NCBICelera
Cytogenetic Map10q32.1NCBI
ACE
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
PanPan1.11762,710,398 - 62,724,018 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1762,702,341 - 62,733,853 (+)Ensemblpanpan1.1panPan2
Mhudiblu_PPA_v01757,556,294 - 57,577,294 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
ACE
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1911,497,182 - 11,516,362 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl911,497,182 - 11,516,358 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha912,457,866 - 12,477,045 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0913,160,704 - 13,179,888 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl913,160,704 - 13,200,795 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1912,105,344 - 12,124,523 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0915,407,255 - 15,426,429 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0915,410,134 - 15,429,354 (-)NCBIUU_Cfam_GSD_1.0
LOC101968921
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440560215,017,159 - 15,036,742 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365414,157,393 - 4,178,177 (+)EnsemblSpeTri2.0
SpeTri2.0NW_0049365414,157,847 - 4,178,156 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
ACE
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1215,394,487 - 15,414,703 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11215,394,487 - 15,414,609 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21215,381,362 - 15,401,171 (-)NCBISscrofa10.2Sscrofa10.2susScr3
Ace
(Heterocephalus glaber - naked mole-rat)
Naked Mole-rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_004624849998,277 - 1,019,521 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_004624849998,262 - 1,019,305 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:1042
Count of miRNA genes:476
Interacting mature miRNAs:539
Transcripts:ENSMUST00000001963, ENSMUST00000001964, ENSMUST00000132280, ENSMUST00000151657
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCm39)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
39128214Lwq20_mliver weight QTL 20 (mouse)1112268637118022724Mouse
4141367Inf1_macute ozone induced inflammation (mouse)Not determined44630038113058009Mouse
4142121Tmc1m2_mTmc1 modifier 2 (mouse)Not determined1156864027114157957Mouse
27226730Tibmd1_mtibia midshaft diameter 1, 5 week (mouse)1162590826109390826Mouse
1301404Sbmd4_mspinal bone mineral density 4 (mouse)Not determined1172019649106019734Mouse
1301310Tmevd5_mTheiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 5 (mouse)Not determined1172726125106726289Mouse
4142348Pstc2_mperiosteal circumference 2 (mouse)Not determined1172818615106818733Mouse
10043866Adip19_madiposity 19 (mouse)Not determined1172818615106818733Mouse
11038695Par8_mpulmonary adenoma resistance 8 (mouse)1177063779111063918Mouse
1301414Heal10_mwound healing/regeneration 10 (mouse)Not determined1177437183111437322Mouse
10045616Heal25_mwound healing/regeneration 25 (mouse)Not determined1177437183111437322Mouse
10413882Moe1_mmodifier of epilepsy 1 (mouse)1177770978111771099Mouse
1301640Lore4_mloss of righting induced by ethanol 4 (mouse)Not determined1179156009107616472Mouse
14746970Manh71_mmandible shape 71 (mouse)1179416257113416257Mouse
1300649Crhq1_mcompensatory renal hypertrophy QTL 1 (mouse)Not determined1181574481115574636Mouse
1300766Skull16_mskull morphology 16 (mouse)Not determined1181574481115574636Mouse
10412288Carg4_mCandida albicans resistance gene 4 (mouse)Not determined1181810267115810267Mouse
1301072Eae22_mexperimental allergic encephalomyelitis 22 (mouse)Not determined1182377698116377820Mouse
14747003Mancz9_mmandible centroid size 9 (mouse)1185844911119844911Mouse
15039374Adip29_madiposity 29 (mouse)1186608320120608320Mouse
15039376Bw42_mbody weight QTL 42 (mouse)1186608320120608320Mouse
15014785Mvlq1_mmacrovesicular liver lesion QTL 1 (mouse)1186608320120608320Mouse
27226789Feml16_mfemur length 16, 10 week (mouse)1187490826121873369Mouse
10044007Hbnr14_mHeligmosomoides bakeri nematode resistance 14 (mouse)Not determined1187502600121502698Mouse
11251723Ewc5_methanol withdrawal and consumption 5 (mouse)1189869251121973369Mouse
1558753Ath19_matherosclerosis 19 (mouse)Not determined1191604608121973369Mouse
1302034Pkccl_mprotein kinase C content in lungs (mouse)Not determined1191604608121973369Mouse
10045617Heal26_mwound healing/regeneration 26 (mouse)Not determined1192939373112544554Mouse
1301095El6_mepilepsy 6 (mouse)Not determined1193229183121973369Mouse
4141939Pregq2_mpregnancy QTL 2 (mouse)Not determined1194063779118022724Mouse
27226731Tibmd4_mtibia midshaft diameter 4, 10 week (mouse)1194190826118890826Mouse
4141465Dbm2_mdiabetes modifier 2 (mouse)Not determined94437183118022724Mouse
1301958Alcp18_malcohol preference locus 18 (mouse)Not determined1195403965121973369Mouse
1300944Alcp20_malcohol preference locus 20 (mouse)Not determined1195403965121973369Mouse
1300962Cd8mts4_mCD8 memory T cell subset 4 (mouse)Not determined1196137674121973369Mouse
1301535Pas5b_mpulmonary adenoma susceptibility 5b (mouse)Not determined1196176465108806384Mouse
1301057Nidd4_mnon-insulin-dependent diabetes mellitus 4 (mouse)Not determined1196810136121973369Mouse
12910539Sstapa3_msuseptibility to Staphylococcus aureus infection 3 (mouse)1196897693110603991Mouse
1301983Berr2_mberghei resistance locus 2 (mouse)Not determined1198352609121973369Mouse
10043976Obq33_mobesity QTL 33 (mouse)Not determined1198500469121973369Mouse
10044001Alcw8_malcohol withdrawal 8 (mouse)Not determined1199254187121973369Mouse
11553867Stmm5_mskin tumor modifier of MSM 5 (mouse)11100058103121973369Mouse
11341721Rvfs2_mRift Valley fever susceptibility 2 (mouse)11100254186120887165Mouse
1301012Vispl_mvisual placing (mouse)Not determined11101022590121973369Mouse
14700693Ppiq12_mprepulse inhibition QTL 12 (mouse)11101504820114472363Mouse
14700694Ppiq13_mprepulse inhibition QTL 13 (mouse)11101504820114472363Mouse
14700695Ppiq14_mprepulse inhibition QTL 14 (mouse)11101504820114472363Mouse
14700696Ppiq15_mprepulse inhibition QTL 15 (mouse)11101504820114472363Mouse
1300957Pbd1_mpeak bone density 1 (mouse)Not determined11102344123112384123Mouse
4141612Cia40_mcollagen induced arthritis 40 (mouse)Not determined11103273992115021444Mouse

Markers in Region
AW208573  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm3811105,989,000 - 105,989,092UniSTSGRCm38
MGSCv3711105,850,314 - 105,850,406UniSTSGRCm37
Celera11117,720,546 - 117,720,638UniSTS
Cytogenetic Map11E1UniSTS
cM Map1165.0UniSTS
Whitehead/MRC_RH111424.74UniSTS
D11Mit13  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm3811105,975,635 - 105,975,795UniSTSGRCm38
MGSCv3711105,836,949 - 105,837,109UniSTSGRCm37
Celera11117,707,159 - 117,707,319UniSTS
Cytogenetic Map11E1UniSTS
cM Map1165.0UniSTS
Whitehead Genetic1165.6UniSTS
Whitehead_YAC11 UniSTS
D10Mit1  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm3811105,975,635 - 105,975,795UniSTSGRCm38
MGSCv3711105,836,949 - 105,837,109UniSTSGRCm37
Celera11117,707,159 - 117,707,319UniSTS
Cytogenetic Map11E1UniSTS
cM Map103.0UniSTS
cM Map106.0UniSTS
cM Map1165.0UniSTS
Whitehead Genetic103.3UniSTS
Whitehead/MRC_RH10159.89UniSTS
D10Wox18  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm3811105,975,646 - 105,975,785UniSTSGRCm38
MGSCv3711105,836,960 - 105,837,099UniSTSGRCm37
Celera11117,707,170 - 117,707,309UniSTS
Cytogenetic Map11E1UniSTS
cM Map1165.0UniSTS
Ace  
Mouse AssemblyChrPosition (strand)SourceJBrowse
GRCm3811105,989,113 - 105,989,238UniSTSGRCm38
MGSCv3711105,850,427 - 105,850,552UniSTSGRCm37
Celera11117,720,659 - 117,720,784UniSTS
Cytogenetic Map11E1UniSTS
cM Map1165.0UniSTS


Expression


Sequence

Nucleotide Sequences
RefSeq Transcripts NM_001281819 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_009598 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_207624 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AK087056 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK154632 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK161020 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK164780 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AL596246 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AL731865 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC034367 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC040404 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC052531 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC083109 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC110362 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BY197083 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BY210311 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH466558 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  J03940 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  J04946 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M34433 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M55333 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M61094 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Reference Sequences
RefSeq Acc Id: ENSMUST00000001963   ⟹   ENSMUSP00000001963
RefSeq Status:
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl11105,858,771 - 105,880,790 (+)Ensembl
GRCm38.p6 Ensembl11105,967,945 - 105,989,964 (+)Ensembl
RefSeq Acc Id: ENSMUST00000001964   ⟹   ENSMUSP00000001964
RefSeq Status:
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl11105,866,034 - 105,880,079 (+)Ensembl
GRCm38.p6 Ensembl11105,975,208 - 105,989,253 (+)Ensembl
RefSeq Acc Id: ENSMUST00000132280   ⟹   ENSMUSP00000119826
RefSeq Status:
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl11105,862,149 - 105,880,086 (+)Ensembl
GRCm38.p6 Ensembl11105,971,323 - 105,989,260 (+)Ensembl
RefSeq Acc Id: ENSMUST00000151657
RefSeq Status:
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl11105,867,431 - 105,875,939 (+)Ensembl
GRCm38.p6 Ensembl11105,976,605 - 105,985,113 (+)Ensembl
RefSeq Acc Id: NM_001281819   ⟹   NP_001268748
RefSeq Status: VALIDATED
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm3911105,858,774 - 105,880,790 (+)NCBI
GRCm3811105,967,948 - 105,989,964 (+)NCBI
Celera11117,699,473 - 117,721,510 (+)NCBI
Sequence:
RefSeq Acc Id: NM_009598   ⟹   NP_033728
RefSeq Status: VALIDATED
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm3911105,866,015 - 105,880,790 (+)NCBI
GRCm3811105,975,189 - 105,989,964 (+)NCBI
MGSCv3711105,829,261 - 105,851,259 (+)RGD
Celera11117,699,473 - 117,721,510 (+)ENTREZGENE
cM Map11 ENTREZGENE
Sequence:
RefSeq Acc Id: NM_207624   ⟹   NP_997507
RefSeq Status: VALIDATED
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm3911105,858,774 - 105,880,790 (+)NCBI
GRCm3811105,967,948 - 105,989,964 (+)NCBI
MGSCv3711105,829,261 - 105,851,259 (+)RGD
Celera11117,699,473 - 117,721,510 (+)ENTREZGENE
cM Map11 ENTREZGENE
Sequence:
Reference Sequences
RefSeq Acc Id: NP_997507   ⟸   NM_207624
- Peptide Label: isoform 1 precursor
- UniProtKB: Q6GTS2 (UniProtKB/Swiss-Prot),   P09470 (UniProtKB/Swiss-Prot),   Q3TU20 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: NP_033728   ⟸   NM_009598
- Peptide Label: isoform 2 precursor
- UniProtKB: P09470 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: NP_001268748   ⟸   NM_001281819
- Peptide Label: isoform 3 precursor
- UniProtKB: Q3TU20 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSMUSP00000119826   ⟸   ENSMUST00000132280
RefSeq Acc Id: ENSMUSP00000001963   ⟸   ENSMUST00000001963
RefSeq Acc Id: ENSMUSP00000001964   ⟸   ENSMUST00000001964

Protein Structures
Name Modeler Protein Id AA Range Protein Structure Video
AF-P09470-F1-model_v2 AlphaFold P09470 1-1312 view protein structure  
ACE N-Terminal pdb 2c6f P09470 35-635 view protein structure  
ACE C-Terminal pdb 108a P09470 636-1237 view protein structure view video

Promoters
RGD ID:6820264
Promoter ID:MM_KWN:10200
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:Lung
Transcripts:OTTMUST00000006415,   UC007LXV.1
Position:
Mouse AssemblyChrPosition (strand)Source
MGSCv3611105,829,191 - 105,829,691 (+)MPROMDB
RGD ID:6820263
Promoter ID:MM_KWN:10202
Type:Non-CpG
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:Lung
Transcripts:ENSMUST00000001964
Position:
Mouse AssemblyChrPosition (strand)Source
MGSCv3611105,835,741 - 105,836,492 (+)MPROMDB
RGD ID:6820265
Promoter ID:MM_KWN:10203
Type:Non-CpG
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:Kidney
Transcripts:OTTMUST00000006418
Position:
Mouse AssemblyChrPosition (strand)Source
MGSCv3611105,836,731 - 105,837,231 (+)MPROMDB
RGD ID:8677042
Promoter ID:EPDNEW_M16552
Type:multiple initiation site
Name:Ace_1
Description:Mus musculus angiotensin I converting enzyme (peptidyl-dipeptidaseA) 1 , transcript variant 2, mRNA.
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm3811105,967,948 - 105,968,008EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene MGI:87874 AgrOrtholog
Ensembl Genes ENSMUSG00000020681 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Protein ENSMUSP00000001963 ENTREZGENE, UniProtKB/Swiss-Prot
  ENSMUSP00000001964 ENTREZGENE, UniProtKB/Swiss-Prot
  ENSMUSP00000119826 ENTREZGENE
  ENSMUSP00000119826.2 UniProtKB/TrEMBL
Ensembl Transcript ENSMUST00000001963 ENTREZGENE, UniProtKB/Swiss-Prot
  ENSMUST00000001964 ENTREZGENE, UniProtKB/Swiss-Prot
  ENSMUST00000132280 ENTREZGENE
  ENSMUST00000132280.8 UniProtKB/TrEMBL
InterPro Peptidase_M2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report mmu:11421 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
MGD MGI:87874 ENTREZGENE
NCBI Gene 11421 ENTREZGENE
PANTHER PTHR10514 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Peptidase_M2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB ACE RGD
PhenoGen Ace PhenoGen
PRINTS PEPDIPTASEA UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PROSITE ZINC_PROTEASE UniProtKB/Swiss-Prot
UniProt ACE_MOUSE UniProtKB/Swiss-Prot
  F6QCP8_MOUSE UniProtKB/TrEMBL
  P09470 ENTREZGENE
  Q3TU20 ENTREZGENE, UniProtKB/TrEMBL
  Q3U3Q7_MOUSE UniProtKB/TrEMBL
  Q5XK22_MOUSE UniProtKB/TrEMBL
  Q6GTS2 ENTREZGENE
  Q7TSV8_MOUSE UniProtKB/TrEMBL
  Q8C339_MOUSE UniProtKB/TrEMBL
  Q8K233_MOUSE UniProtKB/TrEMBL
UniProt Secondary P22967 UniProtKB/Swiss-Prot
  Q6GTS2 UniProtKB/Swiss-Prot